Sector pending / General Medical and Surgical HospitalsUpdated 2026-05-10 22:07 UTC

BST/NH7 stock hub

BST/NH7 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BST/NH7is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1B

Stuttgart Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BST/NH7

In the news

Latest news · BST/NH7

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E10.6

P25 n/aP50 n/aP75 n/a

Trailing P/E13.1

P25 n/aP50 n/aP75 n/a

ROE16.5

P25 n/aP50 n/aP75 n/a

ROIC11.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BST/NH7 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

219

Groups with data

Currency

ZAR

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Africa
Country code	DE
Employees	18,000
Employees Change	-2,370%
Employees Change Percent	-11.63
Enterprise value	EUR 1.7B
Exchange	Stuttgart Stock Exchange
Financial currency	ZAR
First seen	2026-05-10
Industry	General Medical and Surgical Hospitals
Last refreshed	2026-05-10
Market cap	EUR 1.1B
Price	EUR 0.6
Price currency	EUR
Rev Per Employee	72,214.41x
Sic	8062
Symbol	bst/NH7
Website	https://www.netcare.co.za

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.66%
EV Earnings	20.57x
EV/EBIT	9.04x
EV/EBITDA	6.65x
EV/FCF	17.92x
EV/Sales	1.23x
FCF yield	8.79%
Forward P/E	10.63x
P/B ratio	1.97x
P/E ratio	13.06x
P/S ratio	0.82x
PE Ratio10 Y	26.27x
PE Ratio3 Y	11.77x
PE Ratio5 Y	12.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.35%
EBITDA Margin	16.49%
FCF margin	7.22%
Gross margin	49.7%
Gross Profit	EUR 646.1M
Gross Profit Growth	2.13%
Gross Profit Growth Q	4.2%
Gross Profit Growth3 Y	3.12%
Gross Profit Growth5 Y	3.06%
Net Income	EUR 81.7M
Net Income Growth	16.28%
Net Income Growth Q	16.42%
Net Income Growth3 Y	9.22%
Net Income Growth5 Y	7.2%
Pretax Margin	9.58%
Profit Margin	6.62%
Profit Per Employee	EUR 4,539
ROA	7.63
Roa5y	6.22
ROCE	14.92
ROE	16.48
Roe5y	11.98
ROIC	11.44
Roic5y	9.15

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-7.38%
Cagr1y	4.5%
Cagr3y	-0.17%
Cagr5y	-1.55%
Div CAGR10	-2.97%
Div CAGR3	15.37%
Div CAGR5	-9.25%
EPS Growth	22.04
EPS Growth Q	22.69
EPS Growth3 Y	11.27
EPS Growth5 Y	8.91
FCF Growth	51.35%
FCF Growth Q	-21.14%
FCF Growth3 Y	48.12%
FCF Growth5 Y	9.1%
OCF Growth	25.19%
OCF Growth Q	-7.42%
OCF Growth3 Y	17.14%
OCF Growth5 Y	5.49%
Revenue Growth	4.53x
Revenue Growth Q	3.79x
Revenue Growth3 Y	2.88x
Revenue Growth5 Y	2.88x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.91
Assets	EUR 1.4B
Cash	EUR 93.2M
Current Assets	EUR 336.8M
Current Liabilities	EUR 292.4M
Debt	EUR 639.7M
Debt EBITDA	EUR 2.69
Debt Equity	EUR 1.18
Debt FCF	EUR 6.82
Equity	EUR 542.2M
Interest Coverage	3.03
Liabilities	EUR 899.8M
Long Term Assets	EUR 1.1B
Long Term Liabilities	EUR 607.4M
Net Cash	EUR -546.5M
Net Cash By Market Cap	EUR -51.2
Net Debt EBITDA	EUR 2.55
Net Debt Equity	EUR 1.01
Net Debt FCF	EUR 5.83
Tangible Book Value	EUR 403.3M
Tangible Book Value Per Share	EUR 0.34

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.15
Inventory Turnover	24.77
Net Working Capital	EUR 12.9M
Quick ratio	1.02
Working Capital	EUR 42.3M
Working Capital Turnover	EUR 2.66

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	4.01%
Dividend Growth	18.53%
Dividend Growth Years	2%
Dividend per share	EUR 0.04
Dividend Years	5
Dividend Yield	7.12%
Ex Div Date	2026-01-21
Last Dividend	EUR 0.03
Payout Frequency	Semi-Annual
Payout Ratio	54.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-53.56%
1Y total return	4.49%
200-day SMA	0.7
3Y total return	-0.51%
50-day SMA	0.74
50-day SMA vs 200-day SMA	50over200
5Y total return	-7.49%
All Time High	3.35
All Time High Change	-82.09%
All Time High Date	2015-04-29
All Time Low	0.49
All Time Low Change	23.46%
All Time Low Date	2024-04-18
ATR	0.13
Ch YTD	-17.24
High	0.6
High52	0.88
High52 Date	2026-02-27
High52ch	-31.43%
Low	0.6
Low52	0.58
Low52 Date	2025-07-29
Low52ch	4.35%
Ma50ch	-19.05%
Price vs 200-day SMA	-13.68%
RSI	46.37
RSI Monthly	46.16
RSI Weekly	44.45
Sharpe ratio	0.72x
Sortino ratio	1.25
Total Return	11.13%
Tr YTD	-14.59
Tr1m	-26.38%
Tr3m	-23.57%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 173.5M
Operating Income Growth	7.65
Operating Income Growth Q	15.28
Operating Income Growth3 Y	8.39
Operating Income Growth5 Y	6.36
Operating margin	13.35

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,079,049,536%
Net Borrowing	-1,345,913.9
Shares Institutions	85.9%
Shares Qo Q	-0.64%
Shares Yo Y	-4.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 87.7M
Average Volume	0x
Bv Per Share	0.42
CAPEX	EUR -74.2M
Ch10y	-69.25
Ch1m	-26.38
Ch1y	-1.64
Ch3m	-23.57
Ch3y	-15.49
Ch5y	-25.93
Ch6m	-7.69
Change	0%
Change From Open	0
Close	0.6
Days Gap	0
Depreciation Amortization	42,810,415.6
Earnings Date	2026-05-25
EBIT	EUR 173.5M
EBITDA	EUR 214.3M
EPS	EUR 0.07
F Score	6
FCF	EUR 93.8M
FCF EV Yield	5.58x
Financing CF	-91,232,918
Fiscal Year End	September
Founded	1,996
Goodwill	86,811,447.3
Graham Number	0.56123
Graham Upside	-6.46
Income Tax	EUR 35.2M
Investing CF	-72,433,707
Is Primary Listing	0
Last Earnings Date	2026-02-18
Last Report Date	2025-09-30
Lynch Fair Value	EUR 0.33
Lynch Upside	-44.92
Ma150	0.72
Ma150ch	-17.2%
Ma20	0.72
Ma20ch	-17.21%
Net CF	4,292,733
Next Earnings Date	2026-05-25
Open	0.6
P FCF Ratio	11.38
P OCF Ratio	6.35
Payment Date	2026-01-26
Ppne	999,962,269.9
Price Date	2026-05-08
Price EBITDA	EUR 4.98
Ptbv Ratio	2.65
Relative Volume	1,000x
Revenue	1,299,859,378x
SBC By Revenue	0.47x
Share Based Comp	6,118,378
Tax By Revenue	2.71x
Tax Rate	28.26%
Tr6m	-4.73%
Z Score	2.39

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BST/NH7 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+7.1%

$0.04 annual per share

Payout ratio

+54.9%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-9.2%

2 consecutive years of growth

Total shareholder yield

+11.1%

Next ex-dividend date: 2026-01-21

Performance

BST/NH7 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BST/NH7?

Insider, institutional, and short-interest positioning.

Institutional ownership

+85.9%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-4.0%

Negative means the company is buying back shares.

Technical

BST/NH7 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.4

Neutral momentum band

Price vs 200-day MA

-13.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.72

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BST/NH7

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bst/NH7 stock rating?

bst/NH7 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bst/NH7 analysis?

The full report lives at /stocks/bst/NH7/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bst/NH7?

The latest report frames bst/NH7 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bst/NH7 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.